|
      
|
|
|
|
 |
Cover Article
Genetics of Parkinsons Disease Zeros in on Alpha-Synuclein
Recent findings from the ongoing study of a large Iowa kindred have shown that a rare familial form of early-onset Parkinsons disease is caused by four, instead of two, copies of the normal alpha-synuclein gene. The finding also provides further evidence that a given genetic mutation can lead to multiple clinical and pathologic synucleinopathies in one family.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
Therapeutic Cloning Cures Parkinsons-Like Disease in an Animal Model
Researchers have reported the first proof-of-principle demonstration of therapeutic cloning in an animal model of Parkinsons disease. Parkinsonian mice treated with dopaminergic neurons derived from cloned embryonic cells appeared to have permanent relief of their symptoms, and even Lorenz Studer, MD, one of the study authors, was surprised that the therapeutic effect occurs in nearly every single animal.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
First Parkinsons Disease Gene Therapy Administered
A team from New York Weill Cornell Medical Center in New York City recently used a virus to deliver the first gene therapy to a human patient with Parkinsons disease. The goal of this ongoing five-year phase I trial is to restore the normal chemical balance of the subthalamic nucleus by enabling patients with Parkinsons disease to synthesize their own GABA, said Michael G. Kaplitt, MD, PhD, the studys primary investigator.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
Operation Stroke Races Against Time to Save Lives
With the creation of the Dallas Area Stroke Network, Dallas joins more than 125 other US cities participating in Operation Stroke, the American Stroke Associations three-year-old national program designed to mobilize communities to strengthen stroke awareness and optimize treatment availability.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
What to Watch ForClinical Presentations of West Nile Virus
The mosquito season, which runs from July to October, carries with it the seasonal threat of West Nile virus infection. With this possibility, physicians are advised to keep in mind that focal neurologic deficits, polio-like symptoms, gastrointestinal distress, and muscle weakness have
been identified as majorand sometimes unexpectedpresenting symptoms of patients with West Nile virus infection.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
More Bad News From the Womens Health Initiative
Results of the Womens Health Initiative trial of estrogen plus progestin in
16,608 postmenopausal women revealed that combined hormone replacement
therapy increases the risk of stroke, dementia, and global cognitive decline
and does not protect against mild cognitive impairment.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
Smallpox Vaccination Can Lead to Neurologic Complications
Only about 27,000 of the approximately 450,000 health care workers who would
presumably be first responders in the aftermath of a large-scale
bioterrorist attack have opted to receive the smallpox vaccination. For many
who decided against it, fear of vaccine-related complications may have been
a factor in their decision. This article discusses some of the neurologic
complications associated with smallpox vaccination.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
Have We Proven That Stroke Thrombolysis Works?
Two noted stroke experts recently sparred over the question of whether the
research community has amassed enough evidence on t-PAs effectiveness in
acute ischemic stroke to sway clinical practice trends.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
A Window to the Future of Acute Stroke Therapy
A wealth of research has led to major advances in acute stroke, but
substantial hurdles still lie ahead. At the 28th International Stroke
meeting, Marc Fisher, MD, discussed the challenges inherent in developing
therapies that work in a more extended time window.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
Should Epilepsy Surgery Be Considered Sooner Rather Than Later?
Based on the belief that the best treatment for epilepsy is to stop seizures
as soon as possible, the ongoing Early Randomized Surgical Epilepsy Trial
(ERSET) is a head-to-head trial that seeks to determine whether early
surgical intervention or AEDs provide the best opportunity to stop seizures
without side effects.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
Promising New Treatments For Parkinsons Disease
While researchers agree that levodopa remains the gold standard for treating
Parkinsons disease, pursuit of alternatives continues. Trial results for a
host of emerging therapeutics were presented at the 7th International
Congress of Parkinsons Disease and Movement Disorders. Among them were
disappointing updates on the use of fetal stem cell transplants and some
encouraging news about the use of growth factors, implants, novel drug
delivery systems, and a host of drugs, both old and new.
Selected
Articles
|
| |
|
|
|
 |
Cover Article
Can Gene Therapy Protect Against Neurologic Insult?
To date, delivery of neuroprotective genes to the central nervous system via
viral vectors has been limited to laboratory and animal studies but
researchers hope that in the not too distant future, gene therapy may become
a viable tool of clinical neurology.
Selected
Articles
|
| |
Copyright
©2007 by Quadrant HealthCom Inc.
7 Century
Dr, Suite 302
Parsippany, NJ 07054-4609
telephone (973) 206-3434 | fax (973) 206-9378
Advertising: sales@neurologyreviews.com
|